Larvol Delta - Artelo-Biosciences-Receives-Favorable-UK-MHRA-Guidance-for-a-Phase-1-Trial-of-ART1211-the-Companys-Proprietary-CBDTMP-Cocrystal-Being-Developed-for-the-Treatment-of-Anxiety-and-Depression

cannabidiol/tetramethylpyrazine cocrystal (ART12.11) - Artelo Biosci

https://www.globenewswire.com/news-release/2025/08/01/3125723/0/en/Artelo-Biosciences-Receives-Favorable-UK-MHRA-Guidance-for-a-Phase-1-Trial-of-ART12-11-the-Company-s-Proprietary-CBD-TMP-Cocrystal-Being-Developed-for-the-Treatment-of-Anxiety-and-.html

Aug 1, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next